Tritiation of SR141716 by metallation-iodination-reduction: tritium-proton nOe study
Seltzman, H., Carroll, F., Burgess, J., Wyrick, C., & Burch, D. (2002). Tritiation of SR141716 by metallation-iodination-reduction: tritium-proton nOe study. Journal of Labelled Compounds and Radiopharmaceuticals, 45(1), 59-70.
The central cannabinoid receptor antagonist SR141716, N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H -pyrazole-3-carboxamide, was synthesized from commercially available starting materials. Condensation of an aryl hydrazine with a diketone followed by base promoted isomerization/cyclization of the intermediate anti-imine gave the pyrazole acid which was converted to the title hydrazide via its acid chloride. Facile iodination via metallation followed by in situ trapping with an iodine source gave a modest yield of the iodinated SR141716. The iodine was selectively reduced with tritium gas and catalyst while retaining the three aryl chlorine atoms in the structure. The tritiated SR141716 exhibited a tritium-proton nOe both definitively identifying the position of the tritium as well as the sought isomer of the diarylpyrazole. This work provides a direct method for the preparation of preferred iodinated aryl substrates that offer advantages where selectivity and high incorporation in catalytic reduction is sought. Copyright (C) 2002 John Wiley Sons, Ltd